Published in Scand J Gastroenterol Suppl on January 01, 2004
Characteristics of common solid liver lesions and recommendations for diagnostic workup. World J Gastroenterol (2009) 1.32
FDG-PET in diagnosis, staging and prognosis of pancreatic carcinoma: a meta-analysis. World J Gastroenterol (2013) 1.03
Efficacy of 18F-FDG PET/CT in investigation of elevated CEA without known primary malignancy. Indian J Radiol Imaging (2016) 0.75
Approach to Solid Liver Masses in the Cirrhotic Patient. Gastroenterology Res (2009) 0.75
Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis. Gastroenterology (1996) 3.54
Peutz-Jeghers syndrome: a systematic review and recommendations for management. Gut (2010) 3.22
MSH2 mutation carriers are at higher risk of cancer than MLH1 mutation carriers: a study of hereditary nonpolyposis colorectal cancer families. J Clin Oncol (2001) 2.71
Guidelines for radioiodine therapy of differentiated thyroid cancer. Eur J Nucl Med Mol Imaging (2008) 2.67
Guidelines for the clinical management of familial adenomatous polyposis (FAP). Gut (2008) 2.65
Is surveillance of the small bowel indicated for Lynch syndrome families? Gut (2007) 2.42
Increased colorectal cancer risk in first-degree relatives of patients with hyperplastic polyposis syndrome. Gut (2010) 1.94
Value of molecular analysis of Wilson's disease in the absence of tissue copper deposits: a novel ATP7B mutation in an adult patient. Neth J Med (2008) 1.77
Nav1.7-related small fiber neuropathy: impaired slow-inactivation and DRG neuron hyperexcitability. Neurology (2012) 1.73
Clinical radionuclide therapy dosimetry: the quest for the "Holy Gray". Eur J Nucl Med Mol Imaging (2007) 1.71
NaV1.7 gain-of-function mutations as a continuum: A1632E displays physiological changes associated with erythromelalgia and paroxysmal extreme pain disorder mutations and produces symptoms of both disorders. J Neurosci (2008) 1.70
Decision analysis in the surgical treatment of colorectal cancer due to a mismatch repair gene defect. Gut (2003) 1.55
Secondary and tertiary structure modeling reveals effects of novel mutations in polycystic liver disease genes PRKCSH and SEC63. Clin Genet (2010) 1.55
Unfiltered coffee increases plasma homocysteine concentrations in healthy volunteers: a randomized trial. Am J Clin Nutr (2000) 1.52
Value of positron emission tomography with [F-18]fluorodeoxyglucose in patients with colorectal liver metastases: a prospective study. J Clin Oncol (2002) 1.52
A cost-effectiveness analysis of colorectal screening of hereditary nonpolyposis colorectal carcinoma gene carriers. Cancer (1998) 1.49
Effect of etanercept and anakinra on inflammatory attacks in the hyper-IgD syndrome: introducing a vaccination provocation model. Neth J Med (2005) 1.48
Value of fluorodeoxyglucose positron emission tomography in women with breast cancer. Br J Surg (2005) 1.46
FBXO7 mutations cause autosomal recessive, early-onset parkinsonian-pyramidal syndrome. Neurology (2008) 1.45
Chemotherapy response evaluation with FDG-PET in patients with colorectal cancer. Ann Oncol (2007) 1.42
The role of mycophenolate mofetil in the management of autoimmune hepatitis and overlap syndromes. Aliment Pharmacol Ther (2011) 1.42
Maintenance treatment with budesonide 6 mg versus 9 mg once daily in patients with Crohn's disease in remission. Neth J Med (2007) 1.42
Meta-analysis: a functional polymorphism in the gene encoding for activity of the serotonin transporter protein is not associated with the irritable bowel syndrome. Aliment Pharmacol Ther (2007) 1.39
Recommendations to improve identification of hereditary and familial colorectal cancer in Europe. Fam Cancer (2009) 1.38
Cost effectiveness of a new strategy to identify HNPCC patients. Gut (2005) 1.38
The risk of brain tumours in hereditary non-polyposis colorectal cancer (HNPCC). Int J Cancer (1996) 1.35
Germline mutations in APC and MUTYH are responsible for the majority of families with attenuated familial adenomatous polyposis. Clin Genet (2007) 1.32
Mutations in serine protease inhibitor Kazal type 1 are strongly associated with chronic pancreatitis. Gut (2002) 1.29
Systematic review: hypomagnesaemia induced by proton pump inhibition. Aliment Pharmacol Ther (2012) 1.27
Interval cancers in hereditary non-polyposis colorectal cancer (Lynch syndrome) Lancet (1995) 1.25
Somatostatin analogues reduce liver volume in polycystic liver disease. Gut (2008) 1.25
Cutoff value determines the performance of a semi-quantitative immunochemical faecal occult blood test in a colorectal cancer screening programme. Br J Cancer (2009) 1.24
Evaluation of management of desmoid tumours associated with familial adenomatous polyposis in Dutch patients. Br J Cancer (2010) 1.24
The tumour spectrum in hereditary non-polyposis colorectal cancer: a study of 24 kindreds in the Netherlands. Int J Cancer (1990) 1.24
Screening for hereditary non-polyposis colorectal cancer: a study of 22 kindreds in The Netherlands. Am J Med (1989) 1.20
F-18-fluorodeoxyglucose positron emission tomography in diagnosis and follow-up of patients with different types of vasculitis. Neth J Med (2003) 1.19
The long-term outcome of patients with polycystic liver disease treated with lanreotide. Aliment Pharmacol Ther (2011) 1.17
Glycogenic hepatopathy: a rare cause of elevated serum transaminases in diabetes mellitus. Neth J Med (2009) 1.15
Biotransformation enzymes in human intestine: critical low levels in the colon? Gut (1991) 1.14
Beyond RECIST: molecular and functional imaging techniques for evaluation of response to targeted therapy. Cancer Treat Rev (2009) 1.14
Pharmacological management of pain in chronic pancreatitis. Dig Liver Dis (2006) 1.13
Evaluation of a gastrointestinal symptoms questionnaire. Dig Dis Sci (2006) 1.11
[Imaging in the diagnosis of colorectal liver metastases and extrahepatic abnormalities]. Ned Tijdschr Geneeskd (2008) 1.10
Development and clinical application of peptide-based radiopharmaceuticals. Curr Pharm Des (2004) 1.10
Gastric acid-suppressive therapy and community-acquired respiratory infections. Aliment Pharmacol Ther (2003) 1.10
Radioimmunotherapy and colorectal cancer. Br J Surg (2005) 1.10
Long-term results of bilateral thoracoscopic splanchnicectomy in patients with chronic pancreatitis. Br J Surg (2002) 1.09
Clinical heterogeneity of familial colorectal cancer and its influence on screening protocols. Gut (1994) 1.09
Mevalonate kinase deficiency: Evidence for a phenotypic continuum. Neurology (2004) 1.08
FDG-PET in staging lung cancer: how does it change the algorithm? Lung Cancer (2004) 1.08
Radiolabeled compounds in diagnosis of infectious and inflammatory disease. Curr Pharm Des (2004) 1.08
Meta-analysis: the diagnostic value of alarm symptoms for upper gastrointestinal malignancy. Aliment Pharmacol Ther (2004) 1.07
Presymptomatic diagnosis of familial adenomatous polyposis by bridging DNA markers. Lancet (1989) 1.05
Hereditary nonpolyposis colorectal cancer: results of long-term surveillance in 50 families. Eur J Cancer (1995) 1.04
Genetic polymorphisms in UDP-glucuronosyltransferases and glutathione S-transferases and colorectal cancer risk. Carcinogenesis (2004) 1.04
Treatment extension benefits HCV genotype 1 patients without rapid virological response: a systematic review. Neth J Med (2011) 1.04
On-demand anakinra treatment is effective in mevalonate kinase deficiency. Ann Rheum Dis (2011) 1.04
Evaluation of (pre-)malignant colonic abnormalities: endoscopic validation of FDG-PET findings. Eur J Nucl Med (2001) 1.04
Anti-cyclic citrullinated peptide positivity in non-rheumatoid arthritis disease samples: citrulline-dependent or not? Ann Rheum Dis (2006) 1.01
FDG-PET for prediction of survival of patients with metastatic colorectal carcinoma. Ann Oncol (2006) 1.01
Very low incidence of microsatellite instability in rectal cancers from families at risk for HNPCC. Clin Genet (2003) 1.01
Heterozygosity for IL23R p.Arg381Gln confers a protective effect not only against Crohn's disease but also ulcerative colitis. Aliment Pharmacol Ther (2007) 1.00
[Serious complications following (removal after) ingestion of a partial denture]. Ned Tijdschr Tandheelkd (2008) 1.00
Effect of resistant starch on colonic fermentation, bile acid metabolism, and mucosal proliferation. Dig Dis Sci (1994) 0.99
Efficacy of fluorine-18-deoxyglucose positron emission tomography in detecting tumor recurrence after local ablative therapy for liver metastases: a prospective study. J Clin Oncol (2002) 0.99
Hereditary periodic fever and reactive amyloidosis. Clin Exp Med (2005) 0.99
Scintigraphic detection of tumour necrosis factor in patients with rheumatoid arthritis. Ann Rheum Dis (2003) 0.98
Colonic absorption of secondary bile-acids in patients with adenomatous polyps and in matched controls. Lancet (1982) 0.98
Heterozygous alpha-I antitrypsin deficiency as a co-factor in the development of chronic liver disease: a review. Neth J Med (2007) 0.98
Fluorodeoxyglucose-positron emission tomography and sentinel lymph node biopsy in staging primary cutaneous melanoma. Eur J Surg Oncol (2003) 0.98
Effect of transgalactooligosaccharides on the composition of the human intestinal microflora and on putative risk markers for colon cancer. Am J Clin Nutr (1999) 0.98
Diagnostic value of asymmetric striatal D2 receptor upregulation in Parkinson's disease: an [123I]IBZM and [123I]FP-CIT SPECT study. Eur J Nucl Med Mol Imaging (2006) 0.98
WHO consensus statement on the role of nutrition in colorectal cancer. Eur J Cancer Prev (1999) 0.98
Endoscopic placement of biliary endoprostheses in patients with endoscopically unextractable common bile duct stones. A long-term follow up study of 26 patients. Endoscopy (1990) 0.97
Glutathione S-transferases in normal and cancerous human colon tissue. Carcinogenesis (1989) 0.97
Comparison of multiphase CT, FDG-PET and intra-operative ultrasound in patients with colorectal liver metastases selected for surgery. Ann Surg Oncol (2006) 0.96
A case of esophageal duplication cyst with a 13-year follow-up period. Endoscopy (2005) 0.96
Expression of drug-metabolizing enzymes and P-170 glycoprotein in colorectal carcinoma and normal mucosa. Gastroenterology (1992) 0.95
Gastrointestinal symptoms in low-dose aspirin users: a comparison between plain and buffered aspirin. Neth Heart J (2014) 0.95
Glutathione and glutathione S-transferases in Barrett's epithelium. Br J Cancer (1993) 0.95
Aortitis diagnosed by F-18-fluorodeoxyglucose positron emission tomography in a patient with syphilis and HIV coinfection. Infection (2005) 0.94
A comparison between radioimmunotherapy and hyperthermic intraperitoneal chemotherapy for the treatment of peritoneal carcinomatosis of colonic origin in rats. Ann Surg Oncol (2007) 0.94
Effect of ageing on postprandial conjugated and unconjugated serum bile acid levels in healthy subjects. Eur J Clin Invest (1993) 0.94
Approach to genetic analysis in the diagnosis of hereditary autoinflammatory syndromes. Rheumatology (Oxford) (2005) 0.94
Tailoring therapy in colorectal cancer by PET-CT. Q J Nucl Med Mol Imaging (2009) 0.93
Induction of rat hepatic and intestinal UDP-glucuronosyltransferases by naturally occurring dietary anticarcinogens. Carcinogenesis (2003) 0.93
Gastrointestinal disorders and symptoms: does body mass index matter? Neth J Med (2006) 0.93
Complicating infectious foci in patients with Staphylococcus aureus or Streptococcus species bacteraemia. Eur J Clin Microbiol Infect Dis (2007) 0.93
FDG-PET for imaging of non-osseous infection and inflammation. Q J Nucl Med Mol Imaging (2006) 0.93
Gastrointestinal symptoms are still common in a general Western population. Neth J Med (2008) 0.92
Current clinical selection strategies for identification of hereditary non-polyposis colorectal cancer families are inadequate: a meta-analysis. Clin Genet (2004) 0.92
New targeted probes for radioimaging of angiogenesis. Methods (2009) 0.92
Assessment of mandibular invasion of squamous cell carcinoma by various modes of imaging: constructing a diagnostic algorithm. Int J Oral Maxillofac Surg (2008) 0.92
Electronic reminders for pathologists promote recognition of patients at risk for Lynch syndrome: cluster-randomised controlled trial. Virchows Arch (2010) 0.92
Psychopathology is associated with dyspeptic symptom severity in primary care patients with a new episode of dyspepsia. Aliment Pharmacol Ther (2008) 0.91
Epidermal growth factor receptor levels are lower in carcinomatous than in normal colorectal tissue. Br J Cancer (1992) 0.91
Postoperative and long-term results of ileal pouch-anal anastomosis for ulcerative colitis and familial polyposis coli. Dig Dis Sci (1992) 0.91